Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11112-11117
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11112
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11112
Figure 1 Algorithm for prophylaxis to prevent de novo hepatitis B virus for recipients of HBcAb(+) grafts.
For recipients with pretransplant HBsAb > 1000 IU/L, no antiviral prophylaxis is required. Recipients require nucleos(t)ide analogs if HBsAb is < 1000 IU/L. Post-transplant vaccination is given after steroid withdrawal. Nucleos(t)ide analogs may be discontinued if HBsAb is > 1000 IU/L.
-
Citation: Lin CC, Yong CC, Chen CL. Active vaccination to prevent
de novo hepatitis B virus infection in liver transplantation. World J Gastroenterol 2015; 21(39): 11112-11117 - URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11112.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11112